STUDY OF PRACTICES OF BLOOD / BLOOD PRODUCT TRANSFUSION IN A PEDIATRIC INTENSIVE CARE UNIT
Not Applicable
Completed
- Registration Number
- CTRI/2021/05/033701
- Lead Sponsor
- o Sponsor MD Dissertation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 185
Inclusion Criteria
All patients admitted to PICU requiring blood or blood product transfusion (Packed red cells, Platelets & FFP).
Exclusion Criteria
1.Patients in PICU receiving cryoprecipitate / Factor VIII or IX / IVIG/ Other serum products.
2.Patients whose parents/ guardians who refuse to consent to participate in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Frequency of transfusion of blood or blood components (Packed red cells, Platelet concentrate and FFP) in PICU. <br/ ><br>2.Indication and cut offâ??s of various blood parameters (Hemoglobin Hb, platelet counts, Prothrombin time or International Normalized Ratio and Activated Partial Thromboplastin Time) used for transfusions. <br/ ><br>3.Beneficial effect of the transfusion. <br/ ><br>4.Adverse reactions associated with transfusions.Timepoint: Duration of PICU stay
- Secondary Outcome Measures
Name Time Method Compliance of transfusion practices in (our) PICU when compared to the Indian Academy of Pediatrics (IAP) guidelinesTimepoint: Duration of PICU stay;Final outcome (survival/ death) in patients receiving blood/ blood product transfusion.Timepoint: Duration of PICU stay